Compare RVSN & ICU Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | RVSN | ICU |
|---|---|---|
| Founded | 2016 | 2018 |
| Country | Israel | United States |
| Employees | 47 | N/A |
| Industry | | Biotechnology: Pharmaceutical Preparations |
| Sector | | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 10.9M | 9.1M |
| IPO Year | N/A | N/A |
| Metric | RVSN | ICU |
|---|---|---|
| Price | $4.45 | $3.55 |
| Analyst Decision | | |
| Analyst Count | 0 | 0 |
| Target Price | N/A | N/A |
| AVG Volume (30 Days) | 18.1K | ★ 80.3K |
| Earning Date | 03-31-2026 | 05-14-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | N/A |
| EPS | N/A | N/A |
| Revenue | N/A | N/A |
| Revenue This Year | $860.32 | $53.00 |
| Revenue Next Year | N/A | $50.00 |
| P/E Ratio | N/A | N/A |
| Revenue Growth | N/A | N/A |
| 52 Week Low | $0.17 | $0.22 |
| 52 Week High | $9.39 | $5.10 |
| Indicator | RVSN | ICU |
|---|---|---|
| Relative Strength Index (RSI) | 29.87 | 51.60 |
| Support Level | $4.20 | $2.26 |
| Resistance Level | $5.21 | $4.96 |
| Average True Range (ATR) | 0.33 | 0.29 |
| MACD | 0.07 | 0.06 |
| Stochastic Oscillator | 14.28 | 79.43 |
Rail Vision Ltd is an early commercialization stage technology company focused on railway safety systems using AI-integrated sensing systems. The company develops and commercializes proprietary, multi-spectral electro-optic platforms that provide extended-range situational awareness and real-time hazard detection. Using machine learning algorithms to identify and classify obstacles, the company's technology enhances safety, improves operational efficiency, and supports continuity across deployments.
SeaStar Medical Holding Corp is a medical technology company developing proprietary solutions to reduce the consequences of hyperinflammation on vital organs. It is developing and commercializing extracorporeal therapies that target the effector cells that drive systemic inflammation, causing direct tissue damage and secreting a range of pro-inflammatory cytokines that initiate and propagate imbalanced immune responses. The Company is comprised of a single reportable segment, which is its Device Segment.